Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review
United European Gastroenterology Journal · 2023
DOI: 10.1002/ueg2.12454 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift United European Gastroenterology Journal, 2023. Verfasst von Blanca Norero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Portasystemic Shunt, Transjugular Intrahepatic, Liver Neoplasms, Esophageal and Gastric Varices. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Aims Transjugular intrahepatic portosystemic shunts (TIPS) in patients with hepatocellular carcinoma (HCC) may improve access to curative therapies, treat portal hypertension (PH)‐related complications without worsening liver function, and increase overall survival. Data on the efficacy and safety of TIPS to treat PH complications in HCC patients, as well as the HCC treatment response, were evaluated.
Methods
Studies reporting efficacy in controlling bleeding/ascites or response to HCC therapy, safety, and survival in patients with HCC and TIPS were searched systematically on PubMed and Embase. An extraction of articles using predefined data fields and quality indicators was used.
Results
We selected 19 studies and found 937 patients treated for ascites/bleeding and 177 evaluating HCC treatment response. Over half were under 5 cm and solitary lesions, and most studies included tumours with portal vein thrombosis. Regarding PH studies, TIPS resolved bleeding/ascites in >60% of patients, more effective for bleeding. There were no lethal complications reported and procedural bleeding occurred in 40% rate in half of the studies.
Conclusions
In the published studies, TIPS is effective in treating PH complications in patients with HCC. Prospective studies on TIPS placement in patients with HCC are urgently needed to evaluate the efficacy and safety of TIPS in this setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Red de Salud UC Christus; Hospital Dr. Sotero del Rio, Santiago, Chile.
ORCID-Profile: Susana G Rodrigues
Zitieren
APA
Norero, B., Bosch, J., Berzigotti, A., & Rodrigues, S. G. (2023). Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12454
Vancouver
Norero B, Bosch J, Berzigotti A, Rodrigues SG. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review. United European Gastroenterology Journal. 2023. doi:10.1002/ueg2.12454
BibTeX
@article{Norero2023,
author = {Norero, Blanca and Bosch, Jaume and Berzigotti, Annalisa and Rodrigues, Susana G},
title = {Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review},
journal = {United European Gastroenterology Journal},
year = {2023},
doi = {10.1002/ueg2.12454}
}
EUVIMED